ST
RPTP

Spot Trading’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Spot Trading’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-22,600
Closed -$203K – 3571
2016
Q3 		$203K Buy
22,600
+100
+0.4% +$711 ﹤0.01% 2081
2016
Q2 		$121K Buy
+22,500
New +$115K ﹤0.01% 2475
2016
Q1 		– Sell
-164,000
Closed -$853K – 4552
2015
Q4 		$853K Buy
164,000
+88,900
+118% +$516K 0.01% 1572
2015
Q3 		$454K Buy
75,100
+29,600
+65% +$363K ﹤0.01% 2119
2015
Q2 		$718K Buy
45,500
+8,000
+21% +$97.2K 0.01% 1853
2015
Q1 		$408K Sell
37,500
-35,600
-49% -$363K ﹤0.01% 2268
2014
Q4 		$769K Buy
73,100
+41,900
+134% +$409K ﹤0.01% 2055
2014
Q3 		$299K Buy
+31,200
New +$319K ﹤0.01% 2913

Spot Trading's RPTP Position: Q4 2016 in Review

Spot Trading sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 15,452 shares — an estimated $139K sold.

Spot Trading first reported a position in RPTP in Q2 2014 and held it in 10 quarters. The position peaked at $2.32M in Q2 2014. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Spot Trading reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Spot Trading sold 15,452 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $139K.
  • Spot Trading first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2014 and held it in 10 quarters.
  • Spot Trading's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $2.32M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Spot Trading's 13F filing for Q4 2016, filed 7 Feb 2017.